|
Abbott buying biotech firm for $450 million
NEW YORK (AP) — Drug and medical products company Abbott Laboratories said Tuesday it will buyFacet Biotech Corp. for about $450 million in cash, expanding the company's access to biotechnology drugs, including a potential treatment for multiple sclerosis.
|